A reply to the comment: Sherman TEJ, Yu-Wai-Man C, Goyal S, Lim KS. Re: Beckers et al.: Safety and effectiveness of the PRESERFLO® MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. Ophthalmol Glaucoma (2021;doi 10.1016/j.ogla.2021.07.008: Jul 28 [Epub ahead of print].). Ophthalmol Glaucoma. 2022 Jan-Feb;5(1):e1. doi: 10.1016/j.ogla.2021.10.007. Epub 2021 Nov 17. PMID: 34801439.